A detailed history of Los Angeles Capital Management LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 26,513 shares of CORT stock, worth $1.55 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,513
Previous 26,513 -0.0%
Holding current value
$1.55 Million
Previous $861,000 42.39%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$22.21 - $34.48 $495,416 - $769,110
-22,306 Reduced 45.69%
26,513 $861,000
Q1 2024

Apr 05, 2024

SELL
$21.1 - $27.46 $29,540 - $38,444
-1,400 Reduced 2.79%
48,819 $1.23 Million
Q4 2023

Feb 06, 2024

SELL
$24.82 - $32.88 $225,167 - $298,287
-9,072 Reduced 15.3%
50,219 $1.63 Million
Q3 2023

Nov 06, 2023

BUY
$21.97 - $33.8 $1.04 Million - $1.6 Million
47,359 Added 396.91%
59,291 $1.62 Million
Q2 2023

Aug 03, 2023

BUY
$21.44 - $25.15 $43,673 - $51,230
2,037 Added 20.59%
11,932 $265,000
Q1 2023

May 04, 2023

SELL
$19.2 - $24.47 $923,539 - $1.18 Million
-48,101 Reduced 82.94%
9,895 $214,000
Q4 2022

Feb 06, 2023

SELL
$19.95 - $29.96 $99,750 - $149,800
-5,000 Reduced 7.94%
57,996 $1.18 Million
Q3 2022

Nov 02, 2022

BUY
$24.7 - $29.12 $721,585 - $850,711
29,214 Added 86.48%
62,996 $1.62 Million
Q2 2022

Aug 05, 2022

BUY
$17.33 - $25.3 $352,838 - $515,108
20,360 Added 151.69%
33,782 $803,000
Q1 2022

May 06, 2022

BUY
$16.53 - $25.21 $221,865 - $338,368
13,422 New
13,422 $302,000
Q2 2021

Aug 05, 2021

SELL
$19.97 - $24.43 $172,041 - $210,464
-8,615 Closed
0 $0
Q1 2021

May 05, 2021

SELL
$23.49 - $30.56 $154,681 - $201,237
-6,585 Reduced 43.32%
8,615 $204,000
Q4 2020

Feb 04, 2021

SELL
$16.78 - $27.3 $262,103 - $426,426
-15,620 Reduced 50.68%
15,200 $398,000
Q3 2020

Nov 02, 2020

SELL
$12.46 - $19.98 $93,574 - $150,049
-7,510 Reduced 19.59%
30,820 $536,000
Q2 2020

Aug 05, 2020

BUY
$11.0 - $18.26 $226,600 - $376,156
20,600 Added 116.19%
38,330 $644,000
Q1 2020

May 04, 2020

BUY
$10.11 - $14.04 $28,611 - $39,733
2,830 Added 18.99%
17,730 $211,000
Q4 2019

Feb 07, 2020

BUY
$12.06 - $16.96 $179,694 - $252,704
14,900 New
14,900 $180,000
Q1 2019

Apr 25, 2019

SELL
$10.03 - $15.71 $129,316 - $202,549
-12,893 Closed
0 $0
Q4 2018

Feb 11, 2019

SELL
$11.29 - $17.19 $1.08 Million - $1.65 Million
-95,994 Reduced 88.16%
12,893 $172,000
Q3 2018

Nov 05, 2018

BUY
$12.27 - $15.65 $605,463 - $772,249
49,345 Added 82.87%
108,887 $1.53 Million
Q2 2018

Jul 31, 2018

SELL
$15.3 - $19.69 $265,302 - $341,424
-17,340 Reduced 22.55%
59,542 $936,000
Q1 2018

Apr 27, 2018

SELL
$14.59 - $25.5 $1.06 Million - $1.86 Million
-72,960 Reduced 48.69%
76,882 $1.27 Million
Q4 2017

Feb 05, 2018

BUY
$15.77 - $20.72 $1.26 Million - $1.65 Million
79,793 Added 113.91%
149,842 $2.71 Million
Q3 2017

Nov 06, 2017

BUY
$12.3 - $19.3 $669,858 - $1.05 Million
54,460 Added 349.35%
70,049 $1.35 Million
Q2 2017

Aug 09, 2017

BUY
N/A
15,589
15,589 $184,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.27B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.